How good is the management of vascular risk after stroke, transient ischaemic attack or carotid endarterectomy?

Cerebrovascular Diseases

Volumn 23, Issue 2-3, 2007, Pages 156-161

  Johnson, Paul ^a   Rosewell, Mary ^a   James, Martin A ^a  

^a ROYAL DEVON AND EXETER HOSPITAL   (United Kingdom)

Author keywords

Blood pressure; Carotid endarterectomy; Hyperlipidaemia; Stroke, secondary prevention; Transient ischaemic attack

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; CHOLESTEROL; CLOPIDOGREL; DIPYRIDAMOLE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; WARFARIN;

ADULT; AGED; ANTICOAGULANT THERAPY; ARTICLE; BLOOD PRESSURE; CAROTID ENDARTERECTOMY; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DISEASE CONTROL; FEMALE; FOLLOW UP; HEART ATRIUM FIBRILLATION; HUMAN; HYPERCHOLESTEROLEMIA; HYPERLIPIDEMIA; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; PRESCRIPTION; PRIORITY JOURNAL; RISK FACTOR; SINUS RHYTHM; SMOKING; STROKE; TRANSIENT ISCHEMIC ATTACK; TREATMENT DURATION; UNITED KINGDOM;

AGED; AGED, 80 AND OVER; ANTICOAGULANTS; ANTIHYPERTENSIVE AGENTS; ATRIAL FIBRILLATION; BLOOD PRESSURE; CEREBROVASCULAR ACCIDENT; CEREBROVASCULAR DISORDERS; CHOLESTEROL; ENDARTERECTOMY, CAROTID; FEMALE; FIBRINOLYTIC AGENTS; FOLLOW-UP STUDIES; GREAT BRITAIN; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; HYPERLIPIDEMIAS; HYPERTENSION; ISCHEMIC ATTACK, TRANSIENT; MALE; MIDDLE AGED; PLATELET AGGREGATION INHIBITORS; PRACTICE GUIDELINES; RECURRENCE; RETROSPECTIVE STUDIES; RISK FACTORS; SMOKING; SMOKING CESSATION; TIME FACTORS;

EID: 33846908520     PISSN: 10159770     EISSN: None     Source Type: Journal    
DOI: 10.1159/000097053     Document Type: Article

References (32)

1. EAFT (European Atrial Fibrillation Trial) Study Group: Secondary prevention in nonrheumatic atrial fibrillation after transient ischaemic attack or minor stroke. Lancet 1993;342:1255-1262.
2. Antiplatelet Trialists' Collaboration: Collaborative overview of randomised trials of antiplatelet therapy. I. Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. BMJ 1994;308:81-106.
3. Heart Protection Study Collaborative Group: MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet 2002;360:7-22.
4. Hankey GJ, Warlow CP: Treatment and secondary prevention of stroke: evidence, costs, and effects on individuals and populations. Lancet 1999;354:1457-1463.
5. PROGRESS Collaborative Group: Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6,105 individuals with previous stroke or transient ischaemic attack. Lancet 2001;358:1033-1041.
6. The Intercollegiate Working Party for Stroke: National Clinical Guidelines for Stroke, ed 2. London, RCP, 2004.
7. Joseph LN, Babikian VL, Allen NC, Winter MR: Risk factor modification in stroke prevention: the experience of a stroke clinic. Stroke 1999;30:16-20.
8. Mouradian MS, Majumdar SR, Senthilselvan A, Khan K, Shuaib A: How well are hypertension, hyperlipidemia, diabetes, and smoking managed after a stroke or transient ischemic attack? Stroke 2002;33:1656-1659.
9. Barnett HJ, Taylor DW, Eliasziw M, Fox AJ, Ferguson GG, Haynes RB, Rankin RN, Clagett GP, Hachinski VC, Sackett DL, Thorpe KE, Meldrum HE; North American Symptomatic Carotid Endarterectomy Trial Collaborators: Benefit of carotid endarterectomy in patients with symptomatic moderate or severe stenosis. N Engl J Med 1998;339:1415-1425.
10. European Carotid Surgery Trialists' Collaborative Group: Randomised trial of endarterectomy for recently symptomatic carotid stenosis: final results of the MRC European Carotid Surgery Trial (ECST). Lancet 1998;351:1379-1387.
11. The Intercollegiate Working Party for Stroke: National Clinical Guidelines for Stroke. London, RCP, 2000.
12. Halliday A, Mansfield A, Marro J, Peto C, Peto R, Potter J, Thomas D: Prevention of disabling and fatal strokes by successful carotid endarterectomy in patients without recent neurological symptoms: randomised controlled trial. Lancet 2004;363:1491-1502.
13. Roberts CS, Donovan KD, McCarthy PJ, Keagy BA: Frequency of lipid-lowering drug therapy after coronary and carotid operations for atherosclerosis. South Med J 2000;93:424-426.
14. Clopidogrel and modified-release dipyridamole in the prevention of occlusive vascular events. National Institute for Health and Clinical Excellence Technology Appraisal Guidance 90. London, NICE, 2005. www.nice.org.uk/.
15. Wood D, Wray R, Poulter NR, Williams B, Kirby M, Patel V, Durrington P, Reckless J, Davis M, Sivers F, Potter J: Joint British Societies' guidelines on prevention of cardiovascular disease in clinical practice. Heart 2005;91(suppl V):v1-v52.
16. Halkes PH, van GJ, Kappelle LJ, Koudstaal PJ, Algra A: Aspirin plus dipyridamole versus aspirin alone after cerebral ischaemia of arterial origin (ESPRIT): randomized controlled trial. Lancet 2006;367:1665-1673.
17. Bero LA, Grilli R, Grimshaw JM, Harvey E, Oxman AD, Thomson MA: Getting research findings into practice: closing the gap between research and practice - an overview of systematic reviews of interventions to promote the implementation of research findings. BMJ 1998;317:465-468.
18. Cabana MD, Rand CS, Powe NR, Wu AW, Wilson MH, Abboud PA, Rubin HR: Why don't physicians follow clinical practice guidelines? A framework for improvement. JAMA 1999;282:1458-1465.
19. Nelson MR, Reid CM, Krum H, McNeil JJ: Factors influencing family physician adherence to hypertension treatment guideline recommendations on the initiation of pharmacotherapy: questionnaire survey. Am J Cardiovasc Drugs 2003;3:437-441.
20. Gill JM, DiPrinzio MJ: The Medical Society of Delaware's Uniform Clinical Guidelines for diabetes: did they have a positive impact on quality of diabetes care? Del Med J 2004;76:111-122.
21. Rothwell PM: Prevention of stroke in patients with diabetes mellitus and the metabolic syndrome. Cerebrovasc Dis 2005;20(suppl 1):24-34.
22. Griffin S, Kinmonth AL: Diabetes care: the effectiveness of systems for routine surveillance for people with diabetes. Cochrane Database Syst Rev 2000;2:CD000541.
23. Department of Health: Investing in general practice: the new General Medical Services contract. London, Department of Health, 2003.
24. Carroll C, Hobart J, Fox C, Teare L, Gibson J: Stroke in Devon: knowledge was good, but action was poor. J Neurol Neurosurg Psychiatry 2004;75:567-571.
25. Samsa GP, Cohen SJ, Goldstein LB, Bonito AJ, Duncan PW, Enarson C, DeFriese GH, Horner RD, Matchar DB: Knowledge of risk among patients at increased risk for stroke. Stroke 1997;28:916-921.
26. Estrada CA, Hryniewicz MM, Higgs VB, Collins C, Byrd JC: Anticoagulant patient information material is written at high readability levels. Stroke 2000;31:2966-2970.
27. Mazor KM, Billings-Gagliardi S: Does reading about stroke increase stroke knowledge? The impact of different print materials. Patient Educ Couns 2003;51:207-215.
28. Mant J, Carter J, Wade DT, Winner S: The impact of an information pack on patients with stroke and their carers: a randomized controlled trial. Clin Rehabil 1998;12:465-476.
29. Haynes RB, McDonald H, Garg AX, Montague P: Interventions for helping patients to follow prescriptions for medications (Cochrane Review). Chichester, Wiley & Sons, 2004.
30. Walker MK, Whincup PH, Shaper AG, Lennon LT, Thomson AG: Validation of patient recall of doctor-diagnosed heart attack and stroke: a postal questionnaire and record review comparison. Am J Epidemiol 1998;148:355-361.
31. Mant J, Wade D, Winner S: Health care needs assessment: stroke; in Stevens A, Raftery J, Mant J, Simpson S (eds): Health Care Needs Assessment. The Epidemiologically Based Needs Assessment Reviews, ed. 2. Oxford, Radcliffe Medical Press, 2004.
32. Diener HC, Bogousslavsky J, Brass LM, Cimminiello C, Csiba L, Kaste M, Leys D, Matias-Guiu J, Rupprecht HJ: Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, double-blind, placebo-controlled trial. Lancet 2004;364:331-337.